A genetic polymorphism in transforming growth factor beta receptor-2 is associated with serum osteopontin

International Journal of Immunogenetics

Volumn 36, Issue 4, 2009, Pages 241-244

  Biros, E ^a   Clancy, P ^a   Norman, P E ^b   Golledge, J ^a  

^a JAMES COOK UNIVERSITY   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

ADULT; AGED; ARTICLE; DNA POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; COHORT STUDIES; GENE FREQUENCY; HUMANS; MALE; OSTEOPONTIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 67650739257     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2009.00855.x     Document Type: Article

References (20)

1. Agnholt, J., Kelsen, J., Schack, L., Hvas, C.L., Dahlerup, J.F. Sorensen, E.S. (2007) Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease. Scandinavian Journal of Immunology, 65, 453.
2. Chen, Y.F., Feng, J.A., Li, P., Xing, D., Zhang, Y., Serra, R. et al 2006) Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling. Journal of Applied Physiology, 100, 564.
3. Fedarko, N.S., Jain, A., Karadag, A., Van Eman, M.R. Fisher, L.W. (2001) Elevated serum bone sialoprotein and osteopontin in colon, breast, prostate, and lung cancer. Clinical Cancer Research, 7, 4060.
4. Golledge, J., McCann, M., Mangan, S., Lam, A. Karan, M. (2004) Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke, 35, 1636.
5. Golledge, J., Clancy, P., Jamrozik, K. Norman, P.E. (2007a) Obesity, adipokines, and abdominal aortic aneurysm: health in Men study. Circulation, 116, 2275.
6. Golledge, J., Muller, J., Shephard, N., Clancy, P., Smallwood, L., Moran, C. et al 2007b) Association between osteopontin and human abdominal aortic aneurysm. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 655.
7. Golledge, J., Clancy, P., Jones, G.T., Cooper, M., Palmer, L.J., van Rij, A.M. Norman, P.E. (2009) Possible association between genetic polymorphisms in transforming growth factor beta receptors, serum transforming growth factor beta1 concentration and abdominal aortic aneurysm. The British Journal of Surgery, 96, 628.
8. Guo, S.W. Thompson, E.A. (1992) Performing the exact test of Hardy-Weinbreg proportion for multiple alleles. Biometrics, 42, 361.
9. Hullinger, T.G., Pan, Q., Viswanathan, H.L. Somerman, M.J. (2001) TGFbeta and BMP-2 activation of the OPN promoter: roles of smad- and hox-binding elements. Experimental Cell Research, 262, 69.
10. Jamrozik, K., Norman, P.E., Spencer, C.A., Parsons, R.W., Tuohy, R., Lawrence-Brown, M.M. et al 2000) Screening for abdominal aortic aneurysm: lessons from a population-based study. The Medical Journal of Australia, 173, 345.
11. Jin, G., Deng, Y., Miao, R., Hu, Z., Zhou, Y., Tan, Y. et al 2008) TGFB1 and TGFBR.2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population. Journal of Cancer Research and Clinical Oncology, 134, 345.
12. Kadoglou, N.P., Gerasimidis, T., Moumtzouoglou, A., Kapelouzou, A., Sailer, N., Fotiadis, G. et al 2008) Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. European Journal of Vascular and Endovascular Surgery, 35, 661.
13. McKnight, A.J., Savage, D.A., Patterson, C.C., Sadlier, D. Maxwell, A.P. (2007) Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy. BMC Medical Genetics, 8, 5.
14. Michon, I.N., Penning, L.C., Molenaar, T.J., van Berkel, T.J., Biessen, E.A. Kuiper, J. (2002) The effect of TGF-beta receptor binding peptides on smooth muscle cells. Biochemical and Biophysical Research Communications, 293, 1279.
15. Norman, P.E., Jamrozik, K., Lawrence-Brown, M.M., Le, M., Spencer, C.A., Tuohy, R. et al 2004) Impact of screening on mortality from abdominal aortic aneurysm: results of a large, population-based randomised controlled trial. British Medical Journal, 329, 1259.
16. Norman, P.E., Flicker, L., Almeida, O.P., Hankey, G.J., Hyde, Z. Jamrozik, K. (2008) Cohort profile: the health in men study (HIMS). International Journal of Epidemiology, 38, 48.
17. Rahimi, R.A. Leof, E.B. (2007) TGF-beta signaling: a tale of two responses. Journal of Cellular Biochemistry, 102, 593.
18. Scatena, M., Liaw, L. Giachelli, C.M. (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 2302.
19. Wong, C.K., Lit, L.C., Tam, L.S., Li, E.K. Lam, C.W. (2005) Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford), 44, 602.
20. Yamaguchi, H., Igarashi, M., Hirata, A., Tsuchiya, H., Sugiyama, K., Morita, Y. et al 2004) Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients. Endocrine Journal, 51, 499.